Stable Isotope Labelled Enoblituzumab Biosimilar – Anti-CD276/B7-H3 mAb – Research Grade

Reference: PX-TA1410-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Enoblituzumab Biosimilar - Anti-CD276/B7-H3 mAb - Research Grade
SourceCAS 1353485-38-7
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsMG-A271
ReferencePX-TA1410-SIL
Related ProductsPX-P4114
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

Description of Enoblituzumab Biosimilar - Anti-CD276/B7-H3 mAb - Research Grade

General information on Anti-CD276/B7-H3[Homo sapiens] (Enoblituzumab) Monoclonal Antibody

Enoblituzumab is investigated for the treatment of B7-H3-expressing Solid Tumors.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Enoblituzumab Biosimilar – Anti-CD276/B7-H3 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products